Tango Therapeutics, Inc. (TNGX) Insider Trading -- Recent Executive & Director Transactions

15 insiders reported 69 Form 4 transactions for Tango Therapeutics, Inc. (TNGX) over the past 18 months (most recent 2026-09-24). Recent activity: Newcomb Jessica (Principal Accounting Officer) Sell 5,100 shares, Newcomb Jessica (Principal Accounting Officer) Sell 700 shares, Newcomb Jessica (Principal Accounting Officer) Sell 2,400 shares, Crystal Adam (President, R&D) Buy 27,000 shares, Crystal Adam (President, R&D) Sell 27,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-24Newcomb JessicaPrincipal Accounting OfficerSell5,100$122,238
2026-09-24Newcomb JessicaPrincipal Accounting OfficerSell700$15,962
2026-09-24Newcomb JessicaPrincipal Accounting OfficerSell2,400$60,412
2026-09-03Crystal AdamPresident, R&DBuy27,000$140,400
2026-09-03Crystal AdamPresident, R&DSell27,000$603,909
2026-08-05Crystal AdamPresident, R&DBuy27,000$140,400
2026-08-05Crystal AdamPresident, R&DSell5,267$141,100
2026-08-05Crystal AdamPresident, R&DSell21,733$594,417
2026-07-02Crystal AdamPresident, R&DBuy27,000$140,400
2026-07-02Crystal AdamPresident, R&DSell19,629$575,962
2026-07-02Crystal AdamPresident, R&DSell7,371$222,946
2026-06-23Azelby RobertDirectorBuy5,740$0
2026-06-08Ketchum John BDirectorBuy4,000$0
2026-06-08Rothenberg MaceDirectorBuy4,000$0
2026-06-08Calhoun Lesley AnnDirectorBuy4,000$0
2026-06-08Lee SungDirectorBuy570$0
2026-06-03Crystal AdamPresident, R&DBuy27,000$140,400
2026-06-03Crystal AdamPresident, R&DSell6,140$136,615
2026-06-03Crystal AdamPresident, R&DSell20,860$481,032
2026-05-05Crystal AdamPresident, R&DBuy27,000$140,400
2026-05-05Crystal AdamPresident, R&DSell25,900$548,821
2026-05-05Crystal AdamPresident, R&DSell1,100$24,200
2026-05-05Gall MatthewChief Financial OfficerBuy40,000$0
2026-05-01Lee SungDirectorBuy12,300$0
2026-04-16Crystal AdamPresident, R&DBuy38,460$199,992

Source: SEC Form 4 filings · as of 2026-09-24